Providers believe irritable bowel syndrome with mixed diarrhea and constipation is still a challenging disease, Yahoo! Finance reports.
GI & Endoscopy
Mankato, Minn.-based Mayo Clinic Health System is adding a $70 million gastrointestinal endoscopy-facing expansion to its campus, The Mankato Free Press reports.
Laval, Canada-based Valeant Pharmaceuticals CEO Joe Papa said the company is focusing on increasing its revenue and paying down debt at the New York City-based RBC investor conference, Reuters reports.
Flexible sigmoidoscopy provides substantial protection from colorectal cancer for up to 17 years, a study published in The Lancent shows.
Sam Moussa, MD, is a gastroenterologist at Tucson, Ariz.-based Adobe Gastroenterology.
The symbiotic partnership between endoscopists and anesthesiologists could soon be at risk after CMS waived co-payment and deductible responsibilities for colonoscopy patients, according to an Anesthesia Business Consultants' letter.
Caesarea, Israel-based LifeBond is enrolling patients in the United States and Western Europe for its LifeSeal Surgical Sealant's IDE clinical trial.
Prabhakar Swaroop, MD, a gastroenterologist at Hutchinson (Kan.) Clinic, contributed to Conn's Current Therapy 2017, the McPherson Sentinel reports.
Ismail Wadiwala, MD, is a gastroenterologist at Sutter Tracy (Calif.) Community Hospital.
Tel-Aviv, Israel-based RedHill Biopharma treated the last patient enrolled in its Bekinda's 24 mg phase III clinical trial.
